Table 1.
Characteristics of enrolled participants by site.
| Characteristics | Cameroon (n = 156) |
Georgia (n = 270) |
Total (n = 426) |
|---|---|---|---|
| Female | 93 (59.6) | 18 (6.7) | 111 (26.1) |
| Male | 63 (40.4) | 252 (93.3) | 315 (73.9) |
| Median age (range), years | 63 (21–83) | 43 (18–69) | 47 (18–83) |
| Positive HCV antibody | 156 (100) | 181 (67.0) | 337 (79.1) |
| Positive HIV antibody | 2 (1.3) | 3 (1.1) | 5 (1.2) |
| HCV-positive mother | 3 (1.9) | 0 (0.0) | 3 (0.7) |
| Injects non-prescription drugs | 0 (0.0) | 269 (99.6) | 269 (63.1) |
| Treated in past 12 months | 47 (30.1) | 0 (0.0) | 47 (11.0) |
| Abbott HCV RNA undetectable | 64 (41.0) | 149 (55.0) | 213 (50.0) |
| Abbott HCV RNA detectable | 92 (59.0) | 121 (45.0) | 213 (50.0) |
| HCV genotype determined * | 85 (41.5) | 120 (58.5) | 205 (96.2) |
| Genotype 1 † | 33 (38.8) | 75 (62.5) | 108 (52.7) |
| Genotype 2 † | 13 (15.3) | 18 (15.0) | 31 (15.1) |
| Genotype 3 † | 0 (0.0) | 21 (17.5) | 21 (10.2) |
| Genotype 4 † | 38 (44.7) | 0 (0.0) | 38 (18.5) |
| Genotype undetermined † | 1 (1.2) | 6 (5.0) | 7 (3.4) |
Data are number (%) unless otherwise indicated. HCV: Hepatitis C virus; HIV: Human immunodeficiency virus. * The denominator is the number of samples with HCV RNA detected by Abbott HCV RealTime assay. † The denominator is the number of HCV genotypes determined.